ArticleJournal of the American Chemical Society2026
GDP-Loaded K-Ras Transiently Binds to Effector B-Raf RBD, Mirroring the Structure of the Active GTP-Loaded Complex.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- GDP-Loaded K-Ras Transiently Binds to Effector B-Raf RBD, Mirroring the Structure of the Active GTP-Loaded Complex.Journal of the American Chemical Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The Ras-Raf protein association initiates the downstream mitogen-activated protein kinase (MAPK) signaling cascade. This interaction depends on the Ras-nucleotide ligand, whereby Raf preferentially binds to the active guanosine triphosphate (GTP)-loaded state over the guanosine diphosphate (GDP)-loaded state of Ras. Whether GDP-bound Ras can also form specific protein-protein interactions with Raf, however, remains unclear. Here, we characterize the interaction between human K-Ras in both nucleotide states and the Ras-binding domain (RBD) of B-Raf by solution NMR. Active K-Ras·GTP forms a tight, conformationally restricted complex with RBD, causing pronounced chemical shift perturbations at the binding interface consistent with existing cryo-EM and X-ray crystallography structures. Surprisingly, we detect specific binding between "inactive" wild-type K-Ras·GDP with RBD in the millimolar affinity range, whereby the oncogenic G12D mutant of K-Ras further strengthens this interaction. NMR relaxation dispersion and chemical exchange saturation transfer (CEST) experiments allow the detailed structural characterization of the transient K-Ras·GDP·RBD complex, along with the determination of the interaction affinity and kinetics. The results demonstrate that the transient K-Ras·GDP·RBD bound state closely resembles the active K-Ras·GTP·RBD complex, providing a quantitative understanding at the backbone 15N-level of the nucleotide-specific K-Ras-Raf interaction. These findings underscore the prospect of the highly adaptable GDP-bound state of K-Ras for both signaling and as a drug target.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.